BMI KOREA is a leading Contract Development and Manufacturing Organization (CDMO) dedicated to advancing global healthcare through state-of-the-art biopharmaceutical production. With cutting-edge facilities located in Jeju and Osong, South Korea, BMI KOREA provides comprehensive services ranging from research and development to full-scale manufacturing.
Specializing in vial injections, pre-filled syringes, oral dosage forms, and recombinant protein pharmaceuticals, BMI KOREA combines industry-leading technology and rigorous quality control standards to deliver safe, effective, and innovative biopharmaceutical products. Committed to excellence, BMI KOREA continuously expands its capabilities and research infrastructure, positioning itself as a trusted partner in the global pharmaceutical industry.
